Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.

Geburtshilfe und Frauenheilkunde

Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Höcht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prömpeler H, Langrehr J, Leinung S, Beckmann MW, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreißl M, Witteler R, Schorsch A, Mustea A, Petru E, Hübner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Lax S, Runnebaum I, Tempfer C, Nothacker MJ, Blödt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S.
PMID: 30581199
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109. doi: 10.1055/a-0715-2964. Epub 2018 Nov 26.

No abstract available.

Cite
Emons G, Steiner E, Vordermark D, et al. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe Frauenheilkd. 2018;78(11):1089-1109doi: 10.1055/a-0715-2964.
Emons, G., Steiner, E., Vordermark, D., Uleer, C., Bock, N., Paradies, K., Ortmann, O., Aretz, S., Mallmann, P., Kurzeder, C., Hagen, V., van Oorschot, B., Höcht, S., Feyer, P., Egerer, G., Friedrich, M., Cremer, W., Prott, F. J., Horn, L. C., Prömpeler, H., Langrehr, J., Leinung, S., Beckmann, M. W., Kimmig, R., Letsch, A., Reinhardt, M., Alt-Epping, B., Kiesel, L., Menke, J., Gebhardt, M., Steinke-Lange, V., Rahner, N., Lichtenegger, W., Zeimet, A., Hanf, V., Weis, J., Mueller, M., Henscher, U., Schmutzler, R. K., Meindl, A., Hilpert, F., Panke, J. E., Strnad, V., Niehues, C., Dauelsberg, T., Niehoff, P., Mayr, D., Grab, D., Kreißl, M., Witteler, R., Schorsch, A., Mustea, A., Petru, E., Hübner, J., Rose, A. D., Wight, E., Tholen, R., Bauerschmitz, G. J., Fleisch, M., Juhasz-Boess, I., Lax, S., Runnebaum, I., Tempfer, C., Nothacker, M. J., Blödt, S., Follmann, M., Langer, T., Raatz, H., Wesselmann, S., & Erdogan, S. (2018). Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe und Frauenheilkunde, 78(11), 1089-1109. https://doi.org/10.1055/a-0715-2964
Emons, Günter, et al. "Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities." Geburtshilfe und Frauenheilkunde vol. 78,11 (2018): 1089-1109. doi: https://doi.org/10.1055/a-0715-2964
Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Höcht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prömpeler H, Langrehr J, Leinung S, Beckmann MW, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreißl M, Witteler R, Schorsch A, Mustea A, Petru E, Hübner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Lax S, Runnebaum I, Tempfer C, Nothacker MJ, Blödt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities. Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109. doi: 10.1055/a-0715-2964. Epub 2018 Nov 26. PMID: 30581199; PMCID: PMC6261739.
Copy Download .nbib Format: NLM
Availability and use of medications by prehospital providers trained to manage medical complications of patients in hazardous materials incidents.

American journal of disaster medicine

Moses Mhayamaguru K, Gaither JB, French RNE, Christopher ND, Waters KE, Jado I, Rice AD, Beskind D, Knotts MC, Ronnebaum J, Smith J, Walter FG.
PMID: 34904706
Am J Disaster Med. 2021 Summer;16(3):215-223. doi: 10.5055/ajdm.2021.0404.

INTRODUCTION: Little is known about prehospital availability and use of medications to treat patients from hazardous materials (hazmat) medical emergencies. The aim of this study was to identify the availability and frequency of use of medications for patients in...

Cite
Moses Mhayamaguru K, Gaither JB, French RNE, et al. Availability and use of medications by prehospital providers trained to manage medical complications of patients in hazardous materials incidents. Am J Disaster Med. 2021;16(3):215-223doi: 10.5055/ajdm.2021.0404.
Moses Mhayamaguru, K., Gaither, J. B., French, R. N. E., Christopher, N. D., Waters, K. E., Jado, I., Rice, A. D., Beskind, D., Knotts, M. C., Ronnebaum, J., Smith, J., & Walter, F. G. (2021). Availability and use of medications by prehospital providers trained to manage medical complications of patients in hazardous materials incidents. American journal of disaster medicine, 16(3), 215-223. https://doi.org/10.5055/ajdm.2021.0404
Moses Mhayamaguru, K, et al. "Availability and use of medications by prehospital providers trained to manage medical complications of patients in hazardous materials incidents." American journal of disaster medicine vol. 16,3 (2021): 215-223. doi: https://doi.org/10.5055/ajdm.2021.0404
Moses Mhayamaguru K, Gaither JB, French RNE, Christopher ND, Waters KE, Jado I, Rice AD, Beskind D, Knotts MC, Ronnebaum J, Smith J, Walter FG. Availability and use of medications by prehospital providers trained to manage medical complications of patients in hazardous materials incidents. Am J Disaster Med. 2021 Summer;16(3):215-223. doi: 10.5055/ajdm.2021.0404. PMID: 34904706.
Copy Download .nbib Format: NLM
Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series.

Journal of acute care physical therapy

Solon K, Larson A, Ronnebaum J, Stevermer C.
PMID: 34192092
J Acute Care Phys Ther. 2021 Jul;12(3):115-121. doi: 10.1097/JAT.0000000000000153. Epub 2020 Dec 14.

To provide an outline of the timeline from acute care admission to inpatient rehabilitation facility discharge and describe the functional progress and tolerance of 2 individuals who were hospitalized but not intubated because of COVID-19.METHOD: Retrospective data were collected...

Cite
Solon K, Larson A, Ronnebaum J, et al. Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series. J Acute Care Phys Ther. 2020;12(3):115-121doi: 10.1097/JAT.0000000000000153.
Solon, K., Larson, A., Ronnebaum, J., & Stevermer, C. (2021). Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series. Journal of acute care physical therapy, 12(3), 115-121. https://doi.org/10.1097/JAT.0000000000000153
Solon, Kathryn, et al. "Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series." Journal of acute care physical therapy vol. 12,3 (2021): 115-121. doi: https://doi.org/10.1097/JAT.0000000000000153
Solon K, Larson A, Ronnebaum J, Stevermer C. Rehabilitation Outcomes for Patients With Severe Presentation of COVID-19: A Case Series. J Acute Care Phys Ther. 2021 Jul;12(3):115-121. doi: 10.1097/JAT.0000000000000153. Epub 2020 Dec 14. PMID: 34192092; PMCID: PMC8224693.
Copy Download .nbib Format: NLM
Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.

Viruses

Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T.
PMID: 34835130
Viruses. 2021 Nov 21;13(11). doi: 10.3390/v13112324.

The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1)...

Cite
Vollenberg R, Tepasse PR, Ochs K, et al. Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Viruses. 2021;13(11)doi: 10.3390/v13112324.
Vollenberg, R., Tepasse, P. R., Ochs, K., Floer, M., Strauss, M., Rennebaum, F., Kabar, I., Rovas, A., & Nowacki, T. (2021). Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Viruses, 13(11), . https://doi.org/10.3390/v13112324
Vollenberg, Richard, et al. "Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis." Viruses vol. 13,11 (2021). doi: https://doi.org/10.3390/v13112324
Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Viruses. 2021 Nov 21;13(11). doi: 10.3390/v13112324. PMID: 34835130; PMCID: PMC8619155.
Copy Download .nbib Format: NLM
ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids.

American journal of translational research

Daum AK, Dittmann J, Jansen L, Peters S, Dahmen U, Heger JI, Hoppe-Seyler F, Gille A, Clement JH, Runnebaum IB, Dürst M, Backsch C.
PMID: 34650698
Am J Transl Res. 2021 Sep 15;13(9):10298-10314. eCollection 2021.

Cervical cancer (CC) arises from premalignant cervical intraepithelial neoplasia (CIN) induced by a persistent infection with human papillomaviruses. The multi-stepwise disease progression is driven by genetic and epigenetic alterations. Our previous studies demonstrated a clear downregulation of inter-α-trypsin-inhibitor-heavy chain...

Cite
Daum AK, Dittmann J, Jansen L, et al. ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids. Am J Transl Res. 2021;13(9):10298-10314
Daum, A. K., Dittmann, J., Jansen, L., Peters, S., Dahmen, U., Heger, J. I., Hoppe-Seyler, F., Gille, A., Clement, J. H., Runnebaum, I. B., Dürst, M., & Backsch, C. (2021). ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids. American journal of translational research, 13(9), 10298-10314.
Daum, Ann-Kathrin, et al. "ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids." American journal of translational research vol. 13,9 (2021): 10298-10314.
Daum AK, Dittmann J, Jansen L, Peters S, Dahmen U, Heger JI, Hoppe-Seyler F, Gille A, Clement JH, Runnebaum IB, Dürst M, Backsch C. ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids. Am J Transl Res. 2021 Sep 15;13(9):10298-10314. eCollection 2021. PMID: 34650698; PMCID: PMC8507072.
Copy Download .nbib Format: NLM
Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer.

Cancers

Froelich MF, Schnitzer ML, Rathmann N, Tollens F, Unterrainer M, Rennebaum S, Seidensticker M, Ricke J, Rübenthaler J, Kunz WG.
PMID: 33806059
Cancers (Basel). 2021 Mar 25;13(7). doi: 10.3390/cancers13071507.

BACKGROUND: Colorectal cancer is among the most prevalent cancer entities worldwide, with every second patient developing liver metastases during their illness. For local treatment of liver metastases, a surgical approach as well as ablative treatment options, such as microwave...

Cite
Froelich MF, Schnitzer ML, Rathmann N, et al. Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers (Basel). 2021;13(7)doi: 10.3390/cancers13071507.
Froelich, M. F., Schnitzer, M. L., Rathmann, N., Tollens, F., Unterrainer, M., Rennebaum, S., Seidensticker, M., Ricke, J., Rübenthaler, J., & Kunz, W. G. (2021). Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers, 13(7), . https://doi.org/10.3390/cancers13071507
Froelich, Matthias F, et al. "Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer." Cancers vol. 13,7 (2021). doi: https://doi.org/10.3390/cancers13071507
Froelich MF, Schnitzer ML, Rathmann N, Tollens F, Unterrainer M, Rennebaum S, Seidensticker M, Ricke J, Rübenthaler J, Kunz WG. Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers (Basel). 2021 Mar 25;13(7). doi: 10.3390/cancers13071507. PMID: 33806059; PMCID: PMC8037107.
Copy Download .nbib Format: NLM
Charting Shifts in Saccharomyces cerevisiae Gene Expression across Asynchronous Time Trajectories with Diffusion Maps.

mBio

Reiter T, Montpetit R, Runnebaum R, Brown CT, Montpetit B.
PMID: 34607457
mBio. 2021 Oct 26;12(5):e0234521. doi: 10.1128/mBio.02345-21. Epub 2021 Oct 05.

During fermentation, Saccharomyces cerevisiae metabolizes sugars and other nutrients to obtain energy for growth and survival, while also modulating these activities in response to cell-environment interactions. Here, differences in S. cerevisiae gene expression were explored over a time course...

Cite
Reiter T, Montpetit R, Runnebaum R, et al. Charting Shifts in Saccharomyces cerevisiae Gene Expression across Asynchronous Time Trajectories with Diffusion Maps. mBio. 2021;12(5):e0234521doi: 10.1128/mBio.02345-21.
Reiter, T., Montpetit, R., Runnebaum, R., Brown, C. T., & Montpetit, B. (2021). Charting Shifts in Saccharomyces cerevisiae Gene Expression across Asynchronous Time Trajectories with Diffusion Maps. mBio, 12(5), e0234521. https://doi.org/10.1128/mBio.02345-21
Reiter, Taylor, et al. "Charting Shifts in Saccharomyces cerevisiae Gene Expression across Asynchronous Time Trajectories with Diffusion Maps." mBio vol. 12,5 (2021): e0234521. doi: https://doi.org/10.1128/mBio.02345-21
Reiter T, Montpetit R, Runnebaum R, Brown CT, Montpetit B. Charting Shifts in Saccharomyces cerevisiae Gene Expression across Asynchronous Time Trajectories with Diffusion Maps. mBio. 2021 Oct 26;12(5):e0234521. doi: 10.1128/mBio.02345-21. Epub 2021 Oct 05. PMID: 34607457; PMCID: PMC8546541.
Copy Download .nbib Format: NLM
"Locus minoris resistentiae" and connective tissue weakness in older women: a case report and literature review on pelvic organ prolapse with inguinal bladder hernia.

BMC women's health

Esber A, Kopera A, Radosa MP, Runnebaum IB, Mothes HK, Mothes AR.
PMID: 34930209
BMC Womens Health. 2021 Dec 20;21(1):425. doi: 10.1186/s12905-021-01554-4.

BACKGROUND: Conditions such as genital prolapse and hernia are known to be related to connective tissue dysfunction. In this report on cases of the rare simultaneous finding of large genital prolapse and post-prolapse repair female inguinal bladder hernia, we...

Cite
Esber A, Kopera A, Radosa MP, et al. "Locus minoris resistentiae" and connective tissue weakness in older women: a case report and literature review on pelvic organ prolapse with inguinal bladder hernia. BMC Womens Health. 2021;21(1):425doi: 10.1186/s12905-021-01554-4.
Esber, A., Kopera, A., Radosa, M. P., Runnebaum, I. B., Mothes, H. K., & Mothes, A. R. (2021). "Locus minoris resistentiae" and connective tissue weakness in older women: a case report and literature review on pelvic organ prolapse with inguinal bladder hernia. BMC women's health, 21(1), 425. https://doi.org/10.1186/s12905-021-01554-4
Esber, A, et al. ""Locus minoris resistentiae" and connective tissue weakness in older women: a case report and literature review on pelvic organ prolapse with inguinal bladder hernia." BMC women's health vol. 21,1 (2021): 425. doi: https://doi.org/10.1186/s12905-021-01554-4
Esber A, Kopera A, Radosa MP, Runnebaum IB, Mothes HK, Mothes AR. "Locus minoris resistentiae" and connective tissue weakness in older women: a case report and literature review on pelvic organ prolapse with inguinal bladder hernia. BMC Womens Health. 2021 Dec 20;21(1):425. doi: 10.1186/s12905-021-01554-4. PMID: 34930209.
Copy Download .nbib Format: NLM
Vaginal cysts: An important differential diagnosis in the anterior compartment.

European journal of obstetrics, gynecology, and reproductive biology

Esber A, Radosa MP, Wickel J, Mothes HK, Runnebaum IB, Mothes AR.
PMID: 34839250
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:280-284. doi: 10.1016/j.ejogrb.2021.11.422. Epub 2021 Nov 22.

INTRODUCTION: Benign anterior-vaginal-wall cysts (0.5-1% prevalence) often mimic other structures (e.g. cystoceles). No algorithm for their diagnosis, treatment, recurrence or complication prediction can be derived from existing data. Careful preoperative diagnosis can minimize intraoperative surprises and complications due to...

Cite
Esber A, Radosa MP, Wickel J, et al. Vaginal cysts: An important differential diagnosis in the anterior compartment. Eur J Obstet Gynecol Reprod Biol. 2021;267:280-284doi: 10.1016/j.ejogrb.2021.11.422.
Esber, A., Radosa, M. P., Wickel, J., Mothes, H. K., Runnebaum, I. B., & Mothes, A. R. (2021). Vaginal cysts: An important differential diagnosis in the anterior compartment. European journal of obstetrics, gynecology, and reproductive biology, 267280-284. https://doi.org/10.1016/j.ejogrb.2021.11.422
Esber, Anke, et al. "Vaginal cysts: An important differential diagnosis in the anterior compartment." European journal of obstetrics, gynecology, and reproductive biology vol. 267 (2021): 280-284. doi: https://doi.org/10.1016/j.ejogrb.2021.11.422
Esber A, Radosa MP, Wickel J, Mothes HK, Runnebaum IB, Mothes AR. Vaginal cysts: An important differential diagnosis in the anterior compartment. Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:280-284. doi: 10.1016/j.ejogrb.2021.11.422. Epub 2021 Nov 22. PMID: 34839250.
Copy Download .nbib Format: NLM
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance.

Cancers

Hoyer H, Mehlhorn G, Scheungraber C, Hagemann I, Hirchenhain C, Woelber L, Stolte C, Hampl M, Scherbring S, Denecke A, Bartels J, Ebert AD, Meneder S, Petzold A, Heller T, Heidtke KR, Schwarz E, Stübs F, Schütze S, Stange EL, Jaeger A, Martignoni F, Dellmann A, Rody A, Hillemanns P, Fehm T, Petry KU, Böhmer G, Schmalfeldt B, Wimberger P, Beckmann MW, Runnebaum IB, Dürst M.
PMID: 34282754
Cancers (Basel). 2021 Jul 01;13(13). doi: 10.3390/cancers13133309.

PURPOSE: Post-treatment follow-up in women with cervical pre-cancers (CIN3) is mandatory due to relapse in up to 10% of patients. Standard follow-up based on hrHPV-DNA/cytology co-testing has high sensitivity but limited specificity. The aim of our prospective, multicenter, observational...

Cite
Hoyer H, Mehlhorn G, Scheungraber C, et al. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133309.
Hoyer, H., Mehlhorn, G., Scheungraber, C., Hagemann, I., Hirchenhain, C., Woelber, L., Stolte, C., Hampl, M., Scherbring, S., Denecke, A., Bartels, J., Ebert, A. D., Meneder, S., Petzold, A., Heller, T., Heidtke, K. R., Schwarz, E., Stübs, F., Schütze, S., Stange, E. L., Jaeger, A., Martignoni, F., Dellmann, A., Rody, A., Hillemanns, P., Fehm, T., Petry, K. U., Böhmer, G., Schmalfeldt, B., Wimberger, P., Beckmann, M. W., Runnebaum, I. B., & Dürst, M. (2021). Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers, 13(13), . https://doi.org/10.3390/cancers13133309
Hoyer, Heike, et al. "Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133309
Hoyer H, Mehlhorn G, Scheungraber C, Hagemann I, Hirchenhain C, Woelber L, Stolte C, Hampl M, Scherbring S, Denecke A, Bartels J, Ebert AD, Meneder S, Petzold A, Heller T, Heidtke KR, Schwarz E, Stübs F, Schütze S, Stange EL, Jaeger A, Martignoni F, Dellmann A, Rody A, Hillemanns P, Fehm T, Petry KU, Böhmer G, Schmalfeldt B, Wimberger P, Beckmann MW, Runnebaum IB, Dürst M. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers (Basel). 2021 Jul 01;13(13). doi: 10.3390/cancers13133309. PMID: 34282754; PMCID: PMC8269020.
Copy Download .nbib Format: NLM
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Ronnebaum S, Bron M, Patel D, Menno D, Bujanover S, Kratochvil D, Lucas E, Stepnowsky C.
PMID: 34402784
J Clin Sleep Med. 2021 Dec 01;17(12):2543-2555. doi: 10.5664/jcsm.9610.

STUDY OBJECTIVES: Excessive daytime sleepiness associated with obstructive sleep apnea affects 9%-22% of continuous positive airway pressure-treated patients. An indirect treatment comparison meta-analysis was performed to compare efficacy and safety of medications (solriamfetol, modafinil, and armodafinil) approved to treat...

Cite
Ronnebaum S, Bron M, Patel D, et al. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea. J Clin Sleep Med. 2021;17(12):2543-2555doi: 10.5664/jcsm.9610.
Ronnebaum, S., Bron, M., Patel, D., Menno, D., Bujanover, S., Kratochvil, D., Lucas, E., & Stepnowsky, C. (2021). Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 17(12), 2543-2555. https://doi.org/10.5664/jcsm.9610
Ronnebaum, Sarah, et al. "Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea." Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine vol. 17,12 (2021): 2543-2555. doi: https://doi.org/10.5664/jcsm.9610
Ronnebaum S, Bron M, Patel D, Menno D, Bujanover S, Kratochvil D, Lucas E, Stepnowsky C. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea. J Clin Sleep Med. 2021 Dec 01;17(12):2543-2555. doi: 10.5664/jcsm.9610. PMID: 34402784.
Copy Download .nbib Format: NLM
Endometriosis and Beta-hCG > 775 IU/l Increase the Risk of Non-tube-preserving Surgery for Tubal Pregnancy.

Geburtshilfe und Frauenheilkunde

Nicolaus K, Jimenez-Cruz J, Bräuer DM, Lehmann T, Mothes AR, Runnebaum IB.
PMID: 30057425
Geburtshilfe Frauenheilkd. 2018 Jul;78(7):690-696. doi: 10.1055/a-0635-8453. Epub 2018 Jul 25.

INTRODUCTION: Tubal pregnancy is the most clinically relevant form of ectopic pregnancy. Surgery consisting of laparoscopic salpingotomy is the therapeutic gold standard. This study looked at risk factors for non-tube-preserving surgery. The aim was to determine a cut-off value...

Cite
Nicolaus K, Jimenez-Cruz J, Bräuer DM, et al. Endometriosis and Beta-hCG > 775 IU/l Increase the Risk of Non-tube-preserving Surgery for Tubal Pregnancy. Geburtshilfe Frauenheilkd. 2018;78(7):690-696doi: 10.1055/a-0635-8453.
Nicolaus, K., Jimenez-Cruz, J., Bräuer, D. M., Lehmann, T., Mothes, A. R., & Runnebaum, I. B. (2018). Endometriosis and Beta-hCG > 775 IU/l Increase the Risk of Non-tube-preserving Surgery for Tubal Pregnancy. Geburtshilfe und Frauenheilkunde, 78(7), 690-696. https://doi.org/10.1055/a-0635-8453
Nicolaus, Kristin, et al. "Endometriosis and Beta-hCG > 775 IU/l Increase the Risk of Non-tube-preserving Surgery for Tubal Pregnancy." Geburtshilfe und Frauenheilkunde vol. 78,7 (2018): 690-696. doi: https://doi.org/10.1055/a-0635-8453
Nicolaus K, Jimenez-Cruz J, Bräuer DM, Lehmann T, Mothes AR, Runnebaum IB. Endometriosis and Beta-hCG > 775 IU/l Increase the Risk of Non-tube-preserving Surgery for Tubal Pregnancy. Geburtshilfe Frauenheilkd. 2018 Jul;78(7):690-696. doi: 10.1055/a-0635-8453. Epub 2018 Jul 25. PMID: 30057425; PMCID: PMC6059851.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries